These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1369178)

  • 41. Software sensors for the monitoring of perfusion cultures: evaluation of the hybridoma density and the medium composition from glucose concentration measurements.
    Pelletier F; Fonteix C; da Silva AL; Marc A; Engasser JM
    Cytotechnology; 1994; 15(1-3):291-9. PubMed ID: 7765942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High density cultivation of hybridoma in charged porous carriers.
    Ong CP; Pörtner R; Märkl H; Yamazaki Y; Yasuda K; Matsumura M
    J Biotechnol; 1994 May; 34(3):259-68. PubMed ID: 7764959
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of apoptosis in oxygen-deprived cultures of hybridoma cells.
    Mercille S; Massie B
    Cytotechnology; 1994; 15(1-3):117-28. PubMed ID: 7765924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of the Centritech Lab centrifuge for perfusion culture of hybridoma cells in protein-free medium.
    Johnson M; Lanthier S; Massie B; Lefebvre G; Kamen AA
    Biotechnol Prog; 1996; 12(6):855-64. PubMed ID: 8983210
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A perfusion culture system using a stirred ceramic membrane reactor for hyperproduction of IgG2a monoclonal antibody by hybridoma cells.
    Dong H; Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2005; 21(1):140-7. PubMed ID: 15903251
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of metabolism of hybridoma cells cultured in media supplemented with whey or fetal calf serum.
    Legrand C; Capiaumont J; Belleville F; Nabet P
    Biotechnol Prog; 1993; 9(6):573-9. PubMed ID: 7764345
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase of hybridoma productivity using an original dialysis culture system.
    Mathiot B; Perani A; Dumas D; Maugras M; Didelon J; Stoltz JF
    Cytotechnology; 1993; 11(1):41-8. PubMed ID: 7763635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of a membrane-dialysis bioreactor with a radial-flow fixed bed for the cultivation of a hybridoma cell line.
    Bohmann A; Pörtner R; Märkl H
    Appl Microbiol Biotechnol; 1995 Oct; 43(5):772-80. PubMed ID: 7576545
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monoclonal antibody production in dialyzed continuous suspension culture.
    Linardos TI; Kalogerakis N; Behie LA; Lamontagne LR
    Biotechnol Bioeng; 1992 Mar; 39(5):504-10. PubMed ID: 18600976
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dialysis cultures with immobilized hybridoma cells for effective production of monoclonal antibodies.
    Pörtner R; Lüdemann I; Märkl H
    Cytotechnology; 1997 Jan; 23(1-3):39-45. PubMed ID: 22358519
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High density culture of anchorage-dependent animal cells by polyurethane foam packed-bed culture systems.
    Matsushita T; Hidaka H; Kamihata K; Kawakubo Y; Funatsu K
    Appl Microbiol Biotechnol; 1991 May; 35(2):159-64. PubMed ID: 1367366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HBs-MAb production in perfusion culture with selective ammonia removal system.
    Nayve FR; Misato T; Matsumura M; Kataoka H
    J Biotechnol; 1994 May; 34(3):217-25. PubMed ID: 7764955
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stable hybridoma cultivation in a pilot-scale acoustic perfusion system: long-term process performance and effect of recirculation rate.
    Dalm MC; Jansen M; Keijzer TM; van Grunsven WM; Oudshoorn A; Tramper J; Martens DE
    Biotechnol Bioeng; 2005 Sep; 91(7):894-900. PubMed ID: 15959892
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term Continuous Production of Monoclonal Antibody by Hybridoma Cells Immobilized in a Fibrous-Bed Bioreactor.
    Zhu H; Yang ST
    Cytotechnology; 2004 Jan; 44(1-2):1-14. PubMed ID: 19003225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Implementation of a Macroporous Polyhydroxyethylmethacrylate Cryogel-Based Mini-Bioreactor System to Improve Monoclonal Antibody Production.
    Indiramma J; Tetala KKR; Jayaprakash NS
    Front Biosci (Elite Ed); 2024 Aug; 16(3):26. PubMed ID: 39344384
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth kinetics of hybridoma cells: (2) The effects of varying energy source concentrations.
    Low K; Harbour C
    Dev Biol Stand; 1985; 60():73-9. PubMed ID: 4043544
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monoclonal antibody production in hollow fiber bioreactors using serum-free medium.
    Heifetz AH; Braatz JA; Wolfe RA; Barry RM; Miller DA; Solomon BA
    Biotechniques; 1989 Feb; 7(2):192-9. PubMed ID: 2629847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of serum concentration on hybridoma cell growth and monoclonal antibody production at various initial cell densities.
    Lee GM; Huard TK; Palsson BO
    Hybridoma; 1989 Jun; 8(3):369-75. PubMed ID: 2744789
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of operating conditions in production of diagnostic Salmonella Enteritidis O-antigen-specific monoclonal antibody in different bioreactor systems.
    Ayyildiz-Tamis D; Nalbantsoy A; Elibol M; Deliloglu-Gurhan SI
    Appl Biochem Biotechnol; 2014 Jan; 172(1):224-36. PubMed ID: 24068476
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The use of continuous culture to enhance monoclonal antibody production.
    MacMichael GJ
    Hybridoma; 1989 Feb; 8(1):117-26. PubMed ID: 2925207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.